Regarding pharmacotherapeutic approaches to sarcopenia, meta-analyses focused on 10 pharmacological interventions: vitamin D, pioglitazone combined, oestrogen-progesterone, dehydroepiandrosterone, growth hormone, growth hormone-releasing hormone, growth hormone combined with testosterone, insulin-like growth factor1-, testosterone, and ACEi. Here, GH1 is linked to sarcopenia.